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1. IntroductIon
Radiation biodosimetry is an important aspect of 
accidental mass radiological triage assessment and combat. 
While conventional standards for biodosimetry (DCA) prove 
to be accurate and reliable, however, their resource dependence 
and labour intensiveness hinders their utilizations as an ideal 
method for mass casualty assessment and follow-up care. The 
occurrence of any radiological or nuclear event would lead to an 
urgent need for qualitative and quantitative dose assessment for 
follow up medical care and mitigation process management1,2. 
Therefore, it is critically important to identify novel diagnostic 
biomarkers to ensure effective medical treatment3 .Variations 
in the radiation field, heterogeneity of exposure pattern, 
exposure durations, and uncertainties of total-body vs. partial-
body irradiation makes it strenuous to establish the level of 
exposure accurately4,5. Mass hysteria or psychosomatically-
induced symptoms further complicate the triage procedures 
during mass casualty events, especially where potential 
radiation exposure is a major concern. It further suggested the 
need of independent physiological biomarkers of radiation 
exposure6. Present review explains the advance micro-scaling 
microfluidics and BioMEMS techniques for faster, smarter and 
reliable radiation biodosimetric application. 
2. current methods of BIodosImetry
A radiation biodosimeteric marker can be characterized 
as a biological molecule with dose dependent expression 
pattern. This comprises a very large disparate classes of 
molecules and technology platforms, including DNA, RNA 
and protein expression, chromosomal aberration (Dicentric 
Chromosome assay) blood count changes, the metabolites 
identified by Tyburski and colleagues differed from most of 
classical biomarkers of radiation exposure related to oxidative 
damage to DNA structure (e.g., 8-hydroxy-2′-deoxy guanosine 
thymine glycol and thymidine glycol), which also suggested 
that gamma radiation may damage DNA differently than 
other forms of radiation. These potential markers are usually 
evaluated in blood, plasma, urine or saliva samples that are 
readily obtainable in a field setting.
3. dIsadvantages In exIstIng 
radIatIon dose assessment 
methods
Classical research in radiobiology spans various fields 
including the identification and quantification of DNA damage, 
the genes and pathways that are used to repair DNA damage, 
radiation-induced cell death and signalling pathways used to 
signal cell cycle arrest, cellular redox homeostasis, lipid and 
cell membrane damages and the response of mitochondrial 
Microfluidic Integrated Technology: A Potential Tool for  
Portable Radiation Biodosimetry
Shahrukh Khan@, Shravan Kumar#, Shivani Banchariya!, and Raj Kumar#,*
@School of Biotechnology, Gautam Buddha University, Greater Noida - 201 312, India 
#Institute of Nuclear Medicine and Allied Sciences, Delhi - 110 054, India 
!Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, Delhi - 110 025, India 
*E-mail: rajkumar790@yahoo.com 
aBstract
In the event of a mass radiological or nuclear incident, a large number of individuals would require rapid 
biodosimetric screening for proper medical care, mitigation and follow-up procedures. Mass radiological triage is 
critical after any such large-scale event because of the need for Dose assessment of suffered individuals at an early 
stage. With the increasing probability of such unprecedented incidents around the world, the need for modelling 
and development of new medical countermeasures for potential future chemical, biological, radiological and nuclear 
has been well established. Unfortunately, the capacity of most of these methods are still restricted to laboratory 
establishments due to resource limitations, need of high end expertise or general immobility of bulky instruments 
required for the same. So far there exists no rapid diagnostic technique that may reliably discriminate levels of 
ionising radiation exposure based on samples collected at a single time point. In classical clinical settings, complete 
blood count, particularly the lymphocyte count is based on temporal assessment. The diagnostic ‘gold standard’ in 
the field of radiation biodosimetry is the dicentric chromosome assay which happens to be highly labour-intensive 
and extensively time consuming, rendering it inefficient in case of mass casualty situations. Advanced technologies 
such as microfluidic platform, BioMEMS, μTAS carry the potential to make system highly portable, cost efficient 
and independent of high skilled expertise. In this review of the latest advances in portable biodosimetry we evaluate 
our progress and identify areas that still need to be addressed to achieve true field-deployment readiness.
Keywords: Ionising radiation; BioMEMS; Microfluidics; Radiation biodosimetry; Chemilumenescence
Defence Life Science Journal, Vol. 2, No. 3, July 2017, pp. 287-291, DOI : 10.14429/dlsj.2.11666 
 2017, DESIDOC
Received : 17 April 2017, Revised : 30 June 2017
Accepted : 05 July 2017, Online published : 02 August 2017
REVIEW PAPER
288
KhAN, et al.: DEf. LIfE SCI. J., VOL. 2, NO. 3, JuLy 2017, DOI : 10.14429/dlsj.2.11666
metabolism to radiation exposure7. focus has been shifted 
towards easily accessible and non-invasive biomarkers 
identification and validation for radiation dosimetry in order 
to deviate from the conventional labour intensive techniques. 
Conventional biodosimetry methods for epidemiologic 
studies include chromosome aberration, micronucleus assay8 
frequencies from fluorescence in situ hybridisation (fISh) 
of peripheral blood lymphocytes and electron paramagnetic 
resonance (EPR) measurements made on tooth enamel. All 
these techniques require a very high level of precision and 
experience for accuracy in results and risk management which 
may not be available in case of a mass casualty.
While, apex medical institutes of the country like AIIMS, 
New Delhi have introduced workshops on skill development 
for mass casualty triage for medical care providers in the recent 
past and simulation devices and software have been adopted9. 
however, concrete steps have not been taken yet to address 
the CBRN mass casualties. The preparedness of medical 
care-providers in case of radiation mishaps still paints a hazy 
picture10.
The dicentric chromosome assay (DCA) currently the 
standard tool of choice, but being labour-intensive and time-
consuming method11, it is not the most ideal options for mass 
casualty management. Automated dicentric chromosome 
identifier (ADCI) is an image based algorithm software 
available to assist DCA for quicker analysis. A rapid scoring 
approach is also being developed which enables working with 
minimal need for human expertise unable to deliver medical 
grade diagnosis as the chances of misdiagnosis escalate.
Biomarker assessment by conventional methods is a 
very elaborate process requires large amount of sample 
processing time and high level of expertise to achieve 
higher accuracy in results. Instruments like the cell counter, 
karyotyping paraphernalia, hPLC machinery, uPLC and 
Tandem Mass spectroscopy and light microscopes require 
sophisticated positioning and lighting conditions which may 
not always be available during mass casualty incident areas 
of accident.
4. mIcrofluIdIcs
Microfluidics is an engineering devices that allow fluid 
flow to channels smaller than 1 mm in at least one dimension. 
These devices can reduce reagent consumption, allow well 
controlled mixing and particle manipulation, integrate and 
automate multiple assays (known as lab-on-a-chip), and 
facilitate imaging and tracking. Microfluidics encompasses a 
vast number of disciplines and is emerging as a potential tool 
for speeding up processes in the field of biological and chemical 
assay application. Since microfluidics involves micro scaling of 
conventional design of devices, there is an expected alteration 
in physical characteristics of the fluids involved. Keeping these 
anomalies in consideration, microfluidic devices with a lab on 
chip model approach are designed.
5. mIcrofluIdIc Based fIeld 
BIodosImetry
Microfluidics, that can handle small amounts of fluids 
in confined and controlled environment, is an emerging field 
for several years. Some microfluidic devices, though even at 
early stages of development, may help radiobiological research 
particularly to study cellular, tissue and total-body response 
upon irradiation. Microfluidics devices may be used in clinical 
biodosimetry applications. 
6. MIcRofluIdIcs And APPlIcATIon In 
molecular BIology
usage of Arduino based microfluidics chambers for 
DNA extraction holds immense potential in genomic studies 
due to decreased run times and increased specificity of 
overall process due to smoother acceleration and application 
integration to the systemic process12. Genomic studies often 
require the study at nanomole scaled expression of specific 
genes. A microarray is usually employed for such studies as 
it enabled to analyse DNA spots uptofew picomoles. While, 
microarray is a very helpful tool, it has scope of further 
improvement with the help of microfluidics. Electrochemical 
biosensors when engineered with nanomaterials have been 
proven to showcase higher performance in terms of selectivity, 
stability and sensitivity. Also, functional nanomaterials 
when coupled with bio recognition elements can scale up 
biosensing by many folds13. Electrochemical enzymatic and 
aptamer biosensors or aptasensors, based on the integrated 
microchip could revolutionise point-of-care diagnostics and 
environmental monitoring. furthermore, microfluidics can 
enhance clinical diagnostic techniques for analyte assays 
mimicking conventional barcode models and produce high 
throughput results when coupled with micro sensors. A 
microfluidics based chamber with multiple microchannels can 
help to carryout multiple nucleic acid assays in a shorter span 
of time with higher precision and portability (results may be 
obtained on a smartphone device).  Demonstrative studies have 
shown great potential with immunoassays for hIV marker 
proteins13. Development of optical array microchip biosensors 
holds immense potential for label free, expeditious detection 
of multiple bio-hazardous agents ranging from bacterial spore 
to proteinaceous toxins. use of optical microchip sensors 
enables detection of the changes in refractive index due to 
antigen-antibody interaction. Whereas, another microfluidic 
technology includes nanomembrane based nucleic acid 
sensing platforms hold a promising future for DNA/RNA 
analysis making it label-free, reagent-free, faster, highly 
sensitive and the possibility of eliminating the need of PCR 
all together14. Experimental results have shown the major 
cost efficiency for upscalling potential of microfluidics when 
coupled with optics and electronics15. Microfluidic tectonics 
is a comprehensive construction platform for microfluidic 
systems that can help to develop an easy to read colour change 
and disposable ELISA for detection of toxins like botulinum 
utilisation of optical detection provides a cost efficient module 
for lab-on-chip devices owing to be  robust, precise and cost 
efficient devices16.      
Though, gel electrophoresis has been established as an 
excellent technique in molecular biology. however, a newer 
and faster technique has also been developed called capillary 
electrophoresis to scale down the process in dimensions and 
time of performance simultaneously. Microchip electrophoresis 
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is a miniaturised platform of capillary electrophoresis with 
high-throughput, rapid analysis time, lowered consumption 
of sample and solvent, making it highly cost effective17. RT-
PCR is one of the most precise analytical tools and a golden 
standard for the identification of diseases like h1N1. however, 
it is time and labour intensive upto some extent. Development 
of wire guided droplet manipulation and computational fluid 
dynamics has enabled the completion of a PCR reaction of 
thirty cycles (ideal run time of 2 h) in less than ten minutes18. 
These techniques when employed in biodosimetry could 
revolutionise the field of radiation dosimetry, with minimising 
the processing time along with reducing the dependency on 
trained professionals.
7. chemIlumInescence and 
mIcrofluIdIcs
Application of luciferase immunoprecipitation systems 
(LIPS) in microfluidic format for point of care diagnostics of 
infectious and autoimmune diseases has shown impressive 
results with up to 100 per cent sensitivity and specificity in 
experimental researches with hSV-2 infection diagnosis19. 
The use of transparent microfluidics based reaction chip 
has been designed to enable lense-less portable imaging for 
diagnostic purposes using multiplex bioanalysis20. This could 
help in early detection of infectious agents as observed for 
parvovirus B19 DNA. This device can be of aid for early 
detection and follow up care of diseases as well as help in 
estimation of micro dosages in dosimetric analysis leading 
to a better treatment (fig. 1). Similar type of approach can 
be used to to detect and validate radiation biomarker gene or 
protein expression using microfluidic device with precision 
time and sensitivity.  
The portable MOA instrument consist of four wafer 
sandwich which integrates high voltage CE power supplies, 
pneumatic controls and fluorescence detection optics 
necessary for field operation as shown in fig. 2. The amino 
acid concentration sensitivities range from micromolar to 0.1 
nM, corresponding to part-per-trillion sensitivity. 
8. BIodosImetry Based on genomIcs 
And TRAnscRIPToMIcs
Phosphorylated histone γ-h2AX foci has been an 
established radiation biomarker that form at the sites of DNA 
double-strand breaks..γ-h2AX phosphorylation was found to 
be highly linear with radiation doses and thus currently in use 
for radiation biodosimetry at laboratory level. To transform 
the conventional γ-h2AX foci scoring techniques into high-
through-put microfluidic based technique, researchers at 
Oxford university have developed a portable microfluidic 
fluorescence spectrometer. This device can records and 
analysed 10,000 spectra of  γ-h2AX phosphorylating foci in just 
approximately 6 min. Another group developed a microfludic 
device which is capable of evaluating the radiation damage 
of cells by measuring the ratio of the number of cells with γ 
-h2AX fluorescence signals to the total numbers of cells in the 
sample.  The simple prototype of this developed microfluidic 
flow cytometer can detect fluorescent signals corresponding to 
a radiation dose rate as low as 0.95 J/m2, which is very close to 
the detection limit of a commercial confocal microscope, 0.75 
figure 1. different classes of Biomarkers involved in current 
radiation biodosimetry. 
figure 2. The Mars organic Analyser (MoA), a microfabricated capillary electrophoresis (cE) instrument for sensitive amino acid 
biomarker analysis.
(a) (b)
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J/m2. The developed device has many advantages such as low 
cost, easy operation and portability21.
Similarly, a group of researchers at the Center for high-
Throughput Minimally Invasive Radiation Biodosimetry 
at Columbia university Medical Center, New york, have 
developed a fully automated high-throughput system called 
RABIT (Rapid Automated Biodosimetry Tool). This system 
allow to measure γ-h2AX yields from finger stick-derived blood 
samples. These mobile workstation uses purpose-built robotics, 
lymphocyte handling to fully automatic γ-h2AX immune-
cytochemical protocol. Robotic biodosimetry workstation was 
able to detect  dose-dependent increase in γ-h2AX fluorescence 
in irradiated (0-8Gy) peripheral blood samples. 
It was reported earlier that a small group of genes, i.e. 
ASTN2, CDKN1A, GDf15 and ATM, were found to be 
highly predictive of radiation exposure. Expression levels 
of these genes were highly predictive up to 6 Gy dose of 
radiation22,23. Another study evaluated cytokine levels in saliva 
from patients undergoing head and neck radiotherapy. A dose-
response relationship was observed for expression of VEGf, 
MCP-1,EGf, IL-4, IL-6, IL-8, and TNf-a in radiotherapy 
patients22,23. Similarly, miRNA signatures serve as a proof-of-
concept for their utilisation as biomarker of radiation injuries24. 
Microfluidic technique can speed up detection and validation 
of all these radiation biomarker candidates. 
9. conclusIons
It is evident from the above assessments that while 
conventional radiation biodosimetry techniques are reliable to 
a great extent, however, an urgent need for faster, smarter and 
reliable point of care diagnostics is prominent. Conventional 
methods have their limitation like time, resource and labour 
intensive.  In a densely populated country like India, the 
preparedness towards CBRN accidents is an unavoidable 
necessity. Although, DCA, blood based analysis and EPR 
continue to reign as recognised medical standards for 
radiation dose assessment. The use of microfluidics and 
BioMEMS emerges as an excellent tool to aid conventional 
dosimetry techniques and speeding up channels to  fine tune 
the metabolomics and genetics based biodosimeter analysis. 
Microfluidics is helpful in making complex, time dependent 
analytical techniques and thus promising option to expedite 
radiation biodosimetry for emergency applications.
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